Progression to colectomy in the era of biologics: A single center experience with pediatric ulcerative colitis

BACKGROUND/PURPOSE: Clinical outcomes in pediatric ulcerative colitis (UC) in the era of biologic agents are poorly defined. We aimed to describe risk factors for colectomy in pediatric UC in the era of infliximab therapy. METHODS: We reviewed 217 pediatric patients at Texas Children’s Hospital with...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Pediatr Surg
Asıl Yazarlar: Ihekweazu, Faith D., Fofanova, Tatiana, Palacios, Ryan, Ajjarapu, Avanthi, Karam, Lina, Vogel, Adam M., Rodriguez, J R, Kellermayer, Richard
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7396289/
https://ncbi.nlm.nih.gov/pubmed/32087936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpedsurg.2020.01.054
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller